Chen JN - Search Results

1

Arylurea Derivatives: A Class of Potential Cancer Targeting Agents.

Chen JN, Wu DW, Li T, Yang KJ, Cheng L, Zhou ZP, Pu SM, Lin WH. Chen JN, et al. Curr Top Med Chem. 2017 Nov 20;17(28):3099-3130. doi: 10.2174/1568026617666170707123553. Curr Top Med Chem. 2017. PMID: 28685689 Review.

2

Design, synthesis, and biological evaluation of novel quinazolinyl-diaryl urea derivatives as potential anticancer agents.

Chen JN, Wang XF, Li T, Wu DW, Fu XB, Zhang GJ, Shen XC, Wang HS. Chen JN, et al. Eur J Med Chem. 2016 Jan 1;107:12-25. doi: 10.1016/j.ejmech.2015.10.045. Epub 2015 Oct 30. Eur J Med Chem. 2016. PMID: 26560049

3

Synthesis and in vitro anti-bladder cancer activity evaluation of quinazolinyl-arylurea derivatives.

Chen JN, Li T, Cheng L, Qin TS, Sun YX, Chen CT, He YZ, Liu G, Yao D, Wei Y, Li QY, Zhang GJ. Chen JN, et al. Among authors: chen ct. Eur J Med Chem. 2020 Nov 1;205:112661. doi: 10.1016/j.ejmech.2020.112661. Epub 2020 Jul 24. Eur J Med Chem. 2020. PMID: 32827851

4

Synthesis, Fluorescence Properties, and Antiproliferative Potential of Several 3-Oxo-3H-benzo[f]chromene-2-carboxylic Acid Derivatives.

Fu XB, Wang XF, Chen JN, Wu DW, Li T, Shen XC, Qin JK. Fu XB, et al. Among authors: chen jn. Molecules. 2015 Oct 13;20(10):18565-84. doi: 10.3390/molecules201018565. Molecules. 2015. PMID: 26473819 Free PMC article.

5

High in vivo antitumor activity of cobalt oxoisoaporphine complexes by targeting G-quadruplex DNA, telomerase and disrupting mitochondrial functions.

Qin QP, Qin JL, Meng T, Lin WH, Zhang CH, Wei ZZ, Chen JN, Liu YC, Liang H, Chen ZF. Qin QP, et al. Among authors: chen jn, chen zf. Eur J Med Chem. 2016 Nov 29;124:380-392. doi: 10.1016/j.ejmech.2016.08.063. Epub 2016 Aug 28. Eur J Med Chem. 2016. PMID: 27597414

6

Concise synthesis and biological activity evaluation of novel pyrazinyl-aryl urea derivatives against several cancer cell lines, which can especially induce T24 apoptotic and necroptotic cell death.

Chen JN, Chen CT, He YZ, Qin TS, Cheng L, Sun YX, Yang KJ, Chen Q, Yang C, Wei Y. Chen JN, et al. Among authors: chen ct, chen q. RSC Med Chem. 2021 Nov 11;13(3):280-299. doi: 10.1039/d1md00306b. eCollection 2022 Mar 23. RSC Med Chem. 2021. PMID: 35434624 Free PMC article.

7

Correction: Concise synthesis and biological activity evaluation of novel pyrazinyl-aryl urea derivatives against several cancer cell lines, which can especially induce T24 apoptotic and necroptotic cell death.

Chen JN, Chen CT, He YZ, Qin TS, Cheng L, Sun YX, Yang KJ, Chen Q, Yang C, Wei Y. Chen JN, et al. Among authors: chen ct, chen q. RSC Med Chem. 2021 Dec 16;13(3):350. doi: 10.1039/d1md90046c. eCollection 2022 Mar 23. RSC Med Chem. 2021. PMID: 35435611 Free PMC article.

8

Editorial: Multi-target Drug Discovery - Part II.

Chen JN. Chen JN. Curr Top Med Chem. 2017 Nov 20;17(28):3081-3083. doi: 10.2174/156802661728171120143727. Curr Top Med Chem. 2017. PMID: 29197319 No abstract available.

9

Editorial: Multi-target Drug Discovery - Part I.

Chen JN. Chen JN. Curr Top Med Chem. 2017;17(27):2997-2999. doi: 10.2174/156802661727171102165810. Curr Top Med Chem. 2017. PMID: 29113592 No abstract available.

10

Oxoisoaporphine as Potent Telomerase Inhibitor.

Wei ZZ, Qin QP, Chen JN, Chen ZF. Wei ZZ, et al. Among authors: chen jn, chen zf. Molecules. 2016 Nov 14;21(11):1534. doi: 10.3390/molecules21111534. Molecules. 2016. PMID: 27854257 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

461 results

Search Page